CINXE.COM

Overview | Eplontersen for treating hereditary transthyretin-related amyloidosis | Guidance | NICE

<!DOCTYPE html> <html lang="en-GB" class="no-js"> <head> <meta charset="utf-8" /> <meta content="IE=edge,chrome=1" name="X-UA-Compatible" /> <meta content="width=device-width, initial-scale=1" name="viewport" /> <title>Overview | Eplontersen for treating hereditary transthyretin-related amyloidosis | Guidance | NICE</title> <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin /> <link rel="preconnect" href="https://fonts.googleapis.com" crossorigin /> <link rel="preconnect" href="https://code.jquery.com" crossorigin /> <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600&family=Lora:ital,wght@0,600;1,600&display=swap" rel="stylesheet" /> <link href="https://cdn.nice.org.uk/niceorg/css/app.min.css" rel="stylesheet" type="text/css" /> <link href="/css/guidance.nds.css?v=XJ0Id7mMfaqxFlqtEO31pPwT12gwiHDRW9eznDOyfZw" rel="stylesheet" type="text/css" /> <meta content="Evidence-based recommendations on eplontersen (Wainzua) for treating hereditary transthyretin-related amyloidosis in adults" name="Description" /> <meta content="NICE" name="DC.Publisher" /> <meta content="All content on this site is NICE copyright unless otherwise stated. You can download material for private research, study or in-house use only. Do not distribute or publish any material from this site without first obtaining NICE's permission. Where Crown copyright applies, see the Office of Public Sector Information (formerly HMSO) website for information." name="DC.Rights.Copyright" /> <meta content="eng" name="DC.Language" scheme="DCTERMS.ISO639-2T" /> <meta content="Health, well-being and care" name="DC.Subject" scheme="eGMS.IPSV" /> <meta content="Double-A" name="eGMS.accessibility" scheme="eGMS.WCAG10" /> <meta content="Overview | Eplontersen for treating hereditary transthyretin-related amyloidosis | Guidance | NICE" name="DC.Title" /> <meta content="#f6f6f6" name="msapplication-TileColor" /> <meta content="//cdn.nice.org.uk/V3/Content/nice/favicon-144.png" name="msapplication-TileImage" /> <meta content="#333" name="theme-color" /> <link rel="shortcut icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon.ico" /> <link rel="apple-touch-icon-precomposed" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png"> <link rel="apple-touch-icon" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png"> <link rel="apple-touch-icon-precomposed" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png"> <link rel="apple-touch-icon" sizes="120x120" href="//cdn.nice.org.uk/V3/Content/nice/favicon-120.png"> <link rel="apple-touch-icon-precomposed" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png"> <link rel="apple-touch-icon" sizes="152x152" href="//cdn.nice.org.uk/V3/Content/nice/favicon-152.png"> <script src="//cdn.nice.org.uk/cookie-banner/cookie-banner.min.js" type="text/javascript"></script> <script src="https://code.jquery.com/jquery-3.7.1.min.js" integrity="sha384-1H217gwSVyLSIfaLxHbE7dRb3v4mYCKbpQvzx0cegeju1MVsGrX5xXxAvs/HgeFs" crossorigin="anonymous"></script> <script src="https://code.jquery.com/jquery-migrate-3.4.1.min.js" integrity="sha384-ez4i72z0XhJqm0ZRoQkpPN0bDV8Kw8PK3n8kjEZsWhRDrfICLd0AGghHJB+vytx0" crossorigin="anonymous"></script> <script type="text/javascript" src="/js/bundle.min.js?v=d8cjDNlr-MjWTVYMKD3x85tX8TOnpXaUsOCKFLaONKw"></script> <meta name="theme-color" content="#333"><link href="/Media/Default/css/default.css" rel="stylesheet" type="text/css" /><script src="/Media/Default/js/default.js" type="text/javascript"></script> </head> <body data-spy="scroll" data-target=".aside-primary" class=""> <noscript> <iframe src="//www.googletagmanager.com/ns.html?id=GTM-M55QTQ" height="0" width="0" style="display:none;visibility:hidden"></iframe> </noscript> <script> (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src = '//www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-M55QTQ'); </script> <div id="global-nav-header"></div> <div id="printpane"></div> <main> <div class="container" aria-label="Page header"> <nav aria-label="Breadcrumbs" role="navigation"> <p class="visually-hidden" id="breadcrumb-label"> You are here: </p> <ol class="breadcrumbs" aria-labelledby="breadcrumb-label" itemscope itemtype="http://schema.org/BreadcrumbList"> <li class="breadcrumbs__crumb" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/" itemprop="item" data-track="guidancebreadcrumb"> <span itemprop="name"> Home </span> </a> <meta itemprop="position" content="1"> </li> <li class="breadcrumbs__crumb" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/guidance" itemprop="item" data-track="guidancebreadcrumb"> <span itemprop="name"> NICE Guidance </span> </a> <meta itemprop="position" content="2"> </li> <li class="breadcrumbs__crumb" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/guidance/conditions-and-diseases" itemprop="item" data-track="guidancebreadcrumb"> <span itemprop="name"> Conditions and diseases </span> </a> <meta itemprop="position" content="3"> </li> <li class="breadcrumbs__crumb" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/guidance/conditions-and-diseases/diabetes-and-other-endocrinal--nutritional-and-metabolic-conditions" itemprop="item" data-track="guidancebreadcrumb"> <span itemprop="name"> Diabetes and other endocrinal, nutritional and metabolic conditions </span> </a> <meta itemprop="position" content="4"> </li> <li class="breadcrumbs__crumb" itemprop="itemListElement" itemscope itemtype="http://schema.org/ListItem"> <a href="/guidance/conditions-and-diseases/diabetes-and-other-endocrinal--nutritional-and-metabolic-conditions/metabolic-conditions" itemprop="item" data-track="guidancebreadcrumb"> <span itemprop="name"> Metabolic conditions </span> </a> <meta itemprop="position" content="5"> </li> </ol> </nav> <div class="page-header"> <h1 class="page-header__heading" id="content-start"> Eplontersen for treating hereditary transthyretin-related amyloidosis </h1> <ul class="page-header__metadata" aria-label="Product metadata"> <li>Technology appraisal guidance</li> <li><span class="visually-hidden">Reference number: </span>TA1020</li> <li>Published:&nbsp; <time class="show show--ib-xs" datetime="2024-11-27"> 27 November 2024 </time> </li> </ul> <p class="page-header__cta"> <a class="mr--d" href="http://www.nice.org.uk/get-involved/stakeholder-registration/register?t=&amp;p=TA1020&amp;returnUrl=/guidance/ta1020"> Register as a stakeholder </a> </p> </div> </div> <div class="_ layout " aria-label="Main page content"> <div id="toTop"><span aria-hidden="true" class="icon-nice-chevron-up"></span></div> <div class="_"> <div class="content"> <div class="zone zone-content"> <div class="container"> <nav class="horizontal-nav hide-print" aria-label="Sections within this product"> <ul class="horizontal-nav__list"> <li class="horizontal-nav__item"> <a aria-current="true" class="horizontal-nav__link" href="/guidance/ta1020">Guidance</a> </li> <li class="horizontal-nav__item"> <a aria-current="false" class="horizontal-nav__link" href="/guidance/ta1020/resources">Tools and resources</a> </li> <li class="horizontal-nav__item"> <a aria-current="false" class="horizontal-nav__link" href="/guidance/ta1020/informationforpublic">Information for the public</a> </li> <li class="horizontal-nav__item"> <a aria-current="false" class="horizontal-nav__link" href="/guidance/ta1020/evidence">Evidence</a> </li> <li class="horizontal-nav__item"> <a aria-current="false" class="horizontal-nav__link" href="/guidance/ta1020/history">History</a> </li> </ul> </nav> <div class="grid grid--loose"> <div data-g="12 sm:5 md:3" class="hide-print"> <a href="/guidance/ta1020/resources/eplontersen-for-treating-hereditary-transthyretinrelated-amyloidosis-pdf-2973528327509701" target="_blank" class="btn btn--cta mr--0 mb--e mb--d-sm show-ib show-sm text-center" data-track="guidancedownload" data-track-category="guidance download" data-track-action="clicked" data-track-label="/guidance/ta1020/resources/eplontersen-for-treating-hereditary-transthyretinrelated-amyloidosis-pdf-2973528327509701"> Download guidance (PDF) </a> <nav class="stacked-nav" aria-label="Chapters"> <ul class="stacked-nav__list"> <li class="stacked-nav__list-item"> <a aria-current="true" href="/guidance/ta1020"> <span class="stacked-nav__content-wrapper"> Overview </span> </a> </li> <li class="stacked-nav__list-item"> <a aria-current="false" href="/guidance/ta1020/chapter/1-Recommendations"> <span class="stacked-nav__content-wrapper">1 Recommendations</span> </a> </li> <li class="stacked-nav__list-item"> <a aria-current="false" href="/guidance/ta1020/chapter/2-Information-about-eplontersen"> <span class="stacked-nav__content-wrapper">2 Information about eplontersen</span> </a> </li> <li class="stacked-nav__list-item"> <a aria-current="false" href="/guidance/ta1020/chapter/3-Implementation"> <span class="stacked-nav__content-wrapper">3 Implementation</span> </a> </li> <li class="stacked-nav__list-item"> <a aria-current="false" href="/guidance/ta1020/chapter/4-Evaluation-committee-members-and-NICE-project-team"> <span class="stacked-nav__content-wrapper">4 Evaluation committee members and NICE project team</span> </a> </li> </ul> </nav> </div> <div data-g="12 sm:7 md:9"> <div class="grid grid--loose"> <div data-g="12 md:8"> <div class="grid grid--loose grid--rev"> <div data-g="12"> <h2 class="mt--0">Overview</h2> <div class="mb--e js-in-page-nav-target"> <p class="lead"><a href="https://www.nice.org.uk/guidance/TA1020/chapter/1-Recommendations">Evidence-based recommendations</a> on eplontersen (Wainzua) for treating hereditary transthyretin-related amyloidosis in adults.</p> <p><strong>Last reviewed:</strong> 27&nbsp;November&nbsp;2024</p> <p><strong>Next review: </strong>This guidance will be reviewed if there is new evidence that is likely to change the recommendations.</p> <h3>Commercial arrangement</h3> <p>There is a simple discount patient access scheme for eplontersen. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact <a href="mailto:Market.AccessUK@astrazeneca.com">Market.AccessUK@astrazeneca.com</a> for details.</p> <h3>Guidance development process</h3> <p><a href="https://www.nice.org.uk/About/What-we-do/Our-Programmes/NICE-guidance/NICE-technology-appraisal-guidance">How we develop NICE technology appraisal guidance</a></p><div class='panel'><h4 class="title">Your responsibility</h4><p>The recommendations in this guidance represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, health professionals are expected to take this guidance fully into account, alongside the individual needs, preferences and values of their patients. The application of the recommendations in this guidance is at the discretion of health professionals and their individual patients and do not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.</p><p>All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the <a href="https://www.gov.uk/report-problem-medicine-medical-device">Yellow Card Scheme</a>.</p><p>Commissioners and/or providers have a responsibility to provide the funding required to enable the guidance to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities.</p><p>Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should <a href="https://www.nice.org.uk/about/who-we-are/sustainability">assess and reduce the environmental impact of implementing NICE recommendations</a> wherever possible.</p></div> </div> </div> </div> </div> <div data-g="12" class="hide-print"> <hr class="mt--c" /> <div class="prev-next"> <nav aria-label="Previous and next pages"> <a class="prev-next__link" href="/guidance/ta1020/chapter/1-Recommendations" rel="next"> <span class="prev-next__link-intro">Next page</span> <span class="prev-next__link-text">1 Recommendations</span> </a> </nav> </div> </div> </div> </div> </div> </div> </div> </div> </div> </div> </main> <div id="global-nav-footer"></div> <script> var global_nav_config = { service: "guidance", header: { cookie: false, skipLinkId: "content-start", search: { url: "/search", autocomplete: "/autocomplete?ajax=ajax", }, auth: { environment: "live" } } }; </script> <!--[if lt IE 9]> <script src="https://cdn.nice.org.uk/global-nav/global-nav.ie8.min.js" type="text/javascript"></script> <![endif]--> <script src="https://cdn.nice.org.uk/global-nav/global-nav.min.js" type="text/javascript"></script> <script src="//cdn.nice.org.uk/V2/Scripts/twitter.bootstrap.min.js" type="text/javascript"></script> <script src="/Themes/NICE.Bootstrap/scripts/niceorg/NICE.TopScroll.js" type="text/javascript"></script> <script src="//cdn.nice.org.uk/V2/Scripts/NICE.bootstrap.min.js" type="text/javascript"></script> <script src="https://cdn.nice.org.uk/niceorg/js/app.js" async></script> </body> </html>

Pages: 1 2 3 4 5 6 7 8 9 10